SpectraWave Hematology Solutions is closely aligned with the development of SpectraWave Blood Donor Solutions. With a minimal sample volume, results are equivalent to a complete blood count (CBC) including red cell count, white cell count, hemoglobin, MCH, MCHC, and hematocrit levels.  In addition to CBC data, quantifying subtypes of hemoglobin will provide information about diseases such as anemia and diabetes.  The same system will be developed to screen for certain causes of anemia and infections.  This application brings the hematology lab directly to the patient, whether in the hospital, a clinic, a doctor’s office or a remote healthcare station.

Hematology Solutions Demonstration Prototype Q2 2011 Form Factor Study in Africa.

In October 2010, the global non-profit agency, Program for Appropriate Technology in Health (PATH) selected SpectraWave Hematology Solutions to be a rapid, point-of-care diagnostic system for the developing world. Through a $500 thousand grant, U.S. economic and humanitarian agency USAID is funding market and product form factor studies in Africa in 2011 and is also supporting efforts to build global advocacy for this important project. The rapid diagnosis of malaria, anemia and likely causes of infection, is a critical need for improving the health of children and mothers in Africa. The collaboration with PATH is planned to expand to include Walter Reed Army Institute for Research (WRAIR) for the collection and analysis of clinical isolates in Kenya during 2011.